Cardiovascular screening in men aged 60 to 64 years does not reduce all-cause mortality
An invitation to attend a comprehensive screening examination for the early signs of cardiovascular disease (CVD) did not…
Artificial intelligence offers individualized anticoagulation decisions for atrial fibrillation
Bottom Line: Mount Sinai researchers developed an AI model to make individualized treatment recommendations for atrial fibrillation (AF)…
Adding aspirin raises cardiovascular events in high-risk CCS patients on anticoagulants
Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary…
Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major…
Aspirin Confers No Long-Term Heart Benefits in Older Adults
TOPLINE: Healthy older adults who received aspirin experienced no significant long-term benefits against major adverse cardiovascular events (MACE);…